Buyout bosses intend to contest any attempt by competition watchdog to disqualify them as directors of British companies ...

On August 7, 2025, the Food and Drug Administration announced that it would be demanding the elimination of natural thyroid treatment, otherwise known as desiccated thyroid extract (DTE) or natural ...

Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a ...

Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.

Criswell and Dr. Abby Fleish, a pediatric endocrinologist at MaineHealth, are studying whether an older cholesterol-lowering ...

Police walk past a burned car used as a roadblock during a police operation against alleged drug traffickers in the Complexo ...

Taiwan’s Food and Drug Administration has initiated a recall of more than 1.12 million tablets of a thyroid medication ...

Some 77% of patients saw their tumours shrink, 8% saw them completely disappear, and 69% saw partial shrinkage of their tumours.

VISALIA, Calif (KFSN) -- For the first time in over a decade, obesity rates in the US are down, from 39% to 37.7%. Meanwhile, ...

Viridian Therapeutics recently announced a royalty financing agreement with DRI Healthcare Trust, potentially unlocking up to US$300 million to support the commercial launch and development of ...

BBP-418 hit the mark in the phase 3 FORTIFY trial by achieving a significant increase in glycosylated alpha-dystroglycan (αDG), which is impaired in LGMD and causes muscle wasting, initially in the ...